3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Other hematologic neoplasm
2
Myeloid
1
Classical hematology
1
Conditions
Preleukemia
1
Myelodysplastic Syndromes
1
Leukemia
1
Hematologic Diseases
1
Cytopenia
1
Bone Marrow Diseases
1
Anemia
1
Interventions
Azacitidine
62
Cyclophosphamide
49
fludarabine phosphate
46
fludarabine
46
Cytarabine
34
Decitabine
32
venetoclax
27
Tacrolimus
21
Specimen Handling
21
Whole-Body Irradiation
19
Mycophenolic Acid
19
Melphalan
19
Filgrastim
19
Busulfan
19
Imatinib Mesylate
18
ruxolitinib
17
Biopsy
15
Dasatinib
14
Antilymphocyte Serum
14
Granulocyte Colony-Stimulating Factor
13
Etoposide
13
Clofarabine
13
Peripheral Blood Stem Cell Transplantation
12
Sirolimus
11
Methotrexate
11
Ipilimumab
11
Injections
11
Thiotepa
10
Stem Cell Transplantation
10
thymoglobulin
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 1
×
Sertraline
×
Myeloid
×
Clear all
NCT02452983
2022-06-02
SS1
Baylor College of Medicine
Phase 1
Terminated
14 enrolled